Saskatchewan's premier says he will raise his proposal to fund clinical trials of a controversial multiple sclerosis treatment with other premiers next week. (Source: CBC | Health)
Posted: 2010-07-28 15:07:02
More from this author:
Multiple Sclerosis: What Part Do Relapses Play In Severe Disability?
From the Web > MedWorm: Multiple Sclerosis
From the Web > MedWorm: Multiple Sclerosis
Multiple Sclerosis Relapses and Severe Disability
From the Web > MedWorm: Multiple Sclerosis
From the Web > MedWorm: Multiple Sclerosis
Neuronal and BBB damage induced by sera from patients with secondary progressive multiple sclerosis.
From the Web > MedWorm: Multiple Sclerosis
From the Web > MedWorm: Multiple Sclerosis
Stress, Fear, Anxiety and MS
From the Web > About.com Multiple Sclerosis: Most Popular Article
From the Web > About.com Multiple Sclerosis: Most Popular Article
Puusepp's sign—Clinical significance of a forgotten pyramidal sign
From the Web > MedWorm: Multiple Sclerosis
From the Web > MedWorm: Multiple Sclerosis
Related Articles:
[Articles] Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial
From the Web > MedWorm: Multiple Sclerosis
Open-Label Trial
From the Web > About.com Multiple Sclerosis: Most Popular Article
Glatiramer acetate in combination with minocycline in patients with relapsing--remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial
From the Web > Multiple Sclerosis current issue - Sage
Reflexology for the treatment of pain in people with multiple sclerosis: a double-blind randomised sham-controlled clinical trial
From the Web > Multiple Sclerosis RSS feed -- OnlineFirst Article
